Purchase Order 75F40125P00010

Award Date 12/2/24
Potential Completion Date 12/1/25
Potential Value $36K
Ultimate Awardee
Bruker Scientific LLC
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for a pre-inspection, cryocooler servicing, and preventative maintenance service contract on a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit. The contract has a ceiling value of $91,353.96 and is a firm fixed-price purchase order. It does not utilize any set-aside program. The contract was awarded on August 12, 2021, with a final completion date of August...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Bruker Biospin Corp for a preventive maintenance and repair service agreement for cryo-cooler components of Bruker BioSpin 47/40 systems. Valued at two hundred fourteen thousand one hundred eighty-five dollars, this contract supports maintenance of cryogenic cooling equipment through August 2028 without a set-aside designation. As a manufacturer of scientific instruments,...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp. a $21,810 purchase order to provide helium fill maintenance services for a 600 MHz nuclear magnetic resonance spectrometer located in Billerica, Massachusetts. As the prime contractor, Bruker Biospin will perform the requested maintenance through December 2024 on the equipment, which is used to support the FDA's regulatory and research efforts. No subcontractors or set aside designations were...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp a firm fixed price purchase order for $119,796.45 to provide preventive maintenance for an Advance III HD700 nuclear magnetic resonance spectrometer cryoprobe and CryoPlatform system AVHD700X located in Silver Spring, Maryland. The award has a period of performance through February 2025 and includes two optional one-year extension periods. This award responds to a sources sought notification...
The U.S. Food and Drug Administration (FDA) awarded a $145,277.00 firm-fixed-price purchase order contract to Bruker Scientific LLC for preventive maintenance and repair services for a Bruker 7T scimaX mass spectrometer system located at the FDA's National Center for Toxicological Research in Jefferson, Arkansas. The contract has a base period of performance from September 20, 2024, to September 19, 2025, with one option year to September 19, 2026. This award was not set aside for any specific...
The U.S. Food and Drug Administration (FDA) awarded a $195,933.11 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, to acquire a comprehensive service agreement from the original equipment manufacturer (OEM) Bruker. The agreement includes preventive maintenance with two (2) helium refills per year, as well as any repairs and support for a Bruker Avance III HD 600 instrument. The award has an ultimate completion date of August 31, 2027. Bruker...
The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for $168,657.46 to provide service and maintenance for a Bruker Biospec 70/30 magnetic resonance imaging (MRI) cooler and cold head. The contract has a completion date of August 31, 2022. Bruker Biospin Corp is a manufacturer of scientific instruments and provides specialized equipment, maintenance, and support services...
This is a firm fixed price purchase order for a cryo-cooling unit awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The unit is for a Bruker NMR spectrometer system at the FDA's National Center for Toxicological Research. The potential value of the contract is $116,955.00 and there was no...
The Department of Health and Human Services Food and Drug Administration awarded a $120,290.40 firm-fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Cryoprobe/Cryoplatform System Service Agreement. The contract provides for the maintenance and support of specialized cryogenic cooling equipment used in the agency's research and testing programs. This award is not associated with a larger contract vehicle and does not have a set-aside...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...

The U.S. Food and Drug Administration (FDA) awarded a $36,020 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for preventive maintenance and repair services for the cryo-cooler components of a Bruker Biospec 47/40 magnetic resonance imaging (MRI) unit located at the National Center for Toxicological Research (NCTR) in Jefferson, AR. The contract includes one scheduled on-site preventive maintenance service per year, unlimited on-site corrective maintenance/repairs within 3 business days, and 24/7 technical support. This award is not a set-aside procurement. The contract period of performance runs from December 2, 2024, to December 1, 2025. This contract supports the FDA's research and testing programs using specialized analytical equipment.

Generated 11/28/24, 9:08 AM